Franco's project is titled: "Synthetic dosage Lethality of polo-like kinase 1 in colorectal cancer." The award was presented at the annual Santé Awards Evening, held during Health Research Week, and is a chance to recognize the innovative health research happening in Saskatchewan.
Photo L to R: Heather Magotiaux (SHRF CEO), Dr. Franco Vizeacoumar, Don Somers (SHRF Board Chair), Rob Norris (MLA for Saskatoon Greystone)
Share this story